FHTX earnings

Foghorn Therapeutics (FHTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

FHTX earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 9, 20260.80––$83.54M
Q2 2026Aug 6, 2026-0.10––$16.07M
Q1 2026May 7, 2026-0.29––$3.27M
Q4 2025Mar 11, 2026-0.34-0.28-21.43%$9.25M
Q3 2025Nov 5, 2025-0.25-0.3119.35%$8.15M
Q2 2025Aug 5, 2025-0.28-0.319.68%$7.56M
Q1 2025May 14, 2025-0.30-0.300.00%$5.95M
Q4 2024Mar 6, 2025-0.30––$2.86M
Q3 2024Nov 4, 2024-0.31-0.4226.19%$7.81M
Q2 2024Aug 8, 2024-0.45-0.6025.00%$6.89M
Q1 2024May 6, 2024-0.59-0.55-7.27%$5.05M
Q4 2023Mar 7, 2024-0.57-0.7927.85%$5.77M
Q3 2023Nov 2, 2023-0.34––$17.48M
Q2 2023Aug 4, 2023-0.70-0.734.11%$5.60M
Q1 2023May 8, 2023-0.73-0.68-7.35%$5.31M
Q4 2022Mar 9, 2023-0.69-0.59-16.95%$4.18M
Q3 2022Nov 8, 2022-0.62-0.60-3.33%$6.63M